⌕
Synergetics USA · SURG · Nasdaq
Tenet 16 · Weak
Compare
$0.14−2.25%At closeTenet 16 · Weak
$0.140.00 (−2.25%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD

Synergetics USA (SURG) Earnings Forecast

Analysts expect Synergetics USA (SURG) to lose $0.44 a share in FY26, from the one published estimate as of Nov 20, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice
FY26 consensus EPS
$−0.44
1 analyst
FY27 consensus EPS
$0.01
1 analyst · low $0.01, high $0.01
EPS revisions, 30 days
0.0%
$−0.44 to $−0.44

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

One analyst covers this company. Every figure on this page is that one person's estimate rather than an average of several, and it moves on one change of mind.

Consensus as of Nov 20, 2026 · we check it nightly

Analysts expect Synergetics USA to earn $0.01 a share in FY27; 1 analyst publishes an estimate for FY27.

Forward P/E · FY26E
n/m
a multiple of a loss is not meaningful
Range · FY26
None
low, high and average are one number
Coverage · FY26
1 · 1
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $−0.44, a loss that narrowed 37.1% in 90 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 90 days. One step per nightly change.

−101.1%−21.4%+58.2%FY26 +37.1%FY27 −80.0%Aug 22Nov 20
EPS30 days90 daysshown aboveSince Jul 5
FY261 analyst◆ 0.0%$−0.44 to $−0.44▲ +37.1%$−0.70 to $−0.44▲ +37.1%$−0.70 to $−0.44
FY271 analyst◆ 0.0%$0.01 to $0.01▼ −80.0%$0.05 to $0.01▼ −80.0%$0.05 to $0.01
Dec '261 analyst◆ 0.0%$−0.05 to $−0.05▼ −150.0%$−0.02 to $−0.05▼ −150.0%$−0.02 to $−0.05
Mar '271 analyst5 of 30 days0.0% so far5 of 90 days0.0% so far◆ 0.0%$−0.01 to $−0.01

Contributors at both ends of the window: FY26 1 and 1. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price at last close · consensus as of Nov 20, 2026

At 31.1 times earnings, its average over the last five fiscal years, the FY27 consensus of $0.01 works out to $0 a share.

Consensus EPS · FY27
$0.01
1 analyst · thin coverage
Multiple · five-year average P/E
31.1×
Average of the fiscal-year P/Es, FY12 to FY15.
×
Receipt · SURG · FY27Nov 20, 2026
Implied, a share
$0

One analyst covers this year, so the estimate is a single number and there is no low to high band to draw around the answer.

0.01 × 31.1, to the dollar
Drag the multipleShaded: where Synergetics USA's P/E sat at each fiscal year end, FY12 to FY15. Each dot is one year.
20×25×30×35×40×45×48×
10-yr median 27.6×5-yr avg 31.1×$0 a share

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

We hold no forward multiple for Synergetics USA today, so there is nothing here to set against the growth the one analyst covering it expects.Show the multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY12 to FY15 · over 3 fiscal years, with 1 year of near-zero earnings left out. The mark is the median of the last 3.
22.5× low43.2× high
27.6× median
We hold no trailing multiple for this company today, so nothing marks today on the track.

How much do analysts disagree?

One analyst publishes on each year, so there is no range to draw: the low, the high and the average are one number, and a single mark stands for each year.

FY26E1 analyst
$−0.44 · only 1 estimate
FY27E1 analyst
$0.01 · only 1 estimate

The dashed line is FY25 filed $−1.80, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average. Spreads are shown in currency rather than as percentages, because a percentage of a number near zero overstates it.

Is next quarter a high bar or an easy one?

Analysts expect Synergetics USA to lose $0.05 a share in the December quarter, the one estimate published. We hold no expected date for the next report.

Expected report
Not held
No expected date is published for this company's next report, so none is printed here.
Revenue expected · December quarter
$16.2M
1 analyst, 16.2 to 16.2 in $M

For the March quarter, analysts expect a loss of $0.01 a share.

Does Synergetics USA usually beat or miss?

We have not been able to check a quarter yet. Our record of estimates for Synergetics USA begins on Jul 5, 2026, and a quarter can be checked only when we hold an estimate for it from before the company reported.

We started recording estimates on Jul 5, 2026, so quarters that reported before that date cannot be checked.

Before our record
Jan '15
Apr '15
Jul '15
Our record, one quarter per report
Dec '26not reported yet
Mar '27
Jun '27
Sep '27
Dec '27
Mar '28
Jun '28
Sep '28
Dec '28
Mar '29
Jun '29
Sep '29
Checked so far
None yet
one more every report
Beat expectations
Nothing to count
scores begin at the next report
Share price reaction
Not held
there is no checked quarter to measure a reaction for
Typical gap vs estimate
Not yet
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Synergetics USA on Jul 5, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact.

The one analyst covering it expects sales to grow 8.0% in FY27. Consensus EPS is a loss in FY26, so there is no EPS growth rate to take apart.

1 analyst publishes an EPS estimate for FY26 and 1 publishes revenue. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
11
FY26E
11
FY27E
The FY26 panel has held 1 analyst every night since our record of it began on Jul 5, 2026.

The full consensus, year by year

Consensus as of Nov 20, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
0.10.10.1historyStreet forecastFY22FY25FY27E

Coverage thins with distance: 1 revenue estimates for FY26, 1 for FY27.

Diluted EPS · $filed · consensus average · band = low to high
−2.62−0.541.53historyStreet forecastFY22FY25FY27E

Out-year bands widen as fewer analysts publish: 1 EPS estimates for FY26, 1 for FY27.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed0.1—−1.80————as filed—
FY26E0.10.1 to 0.1▲13.9%a−0.44−0.44 to −0.44n/ca−0.0−0.00.021 · 1n/m
FY27E0.10.1 to 0.1▲8.0%0.010.01 to 0.01—0.00.00.021 · 113.9×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 1 EPS estimates for FY26. Not investment advice.

What do analysts expect Synergetics USA to earn in FY26?

The one analyst covering Synergetics USA expects it to lose $0.44 a share in FY26, as of Nov 20, 2026.

What is Synergetics USA's earnings forecast for FY27?

The FY27 consensus for Synergetics USA is $0.01 a share from 1 analyst, as of Nov 20, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.